Chinese Journal of Tissue Engineering Research ›› 2019, Vol. 23 ›› Issue (19): 3050-3055.doi: 10.3969/j.issn.2095-4344.1250

Previous Articles     Next Articles

Methylprednisolone inhibits inflammation mediated by activated microglia after spinal cord injury in rat models 

Huang Xingqiu, Liao Xuqiang, Shi Chenglong, Zhang Xiuli   

  1. (the First People’s Hospital of Foshan, Foshan 528000, Guangdong Province, China)
  • Received:2018-12-26
  • Contact: Zhang Xiuli, Associate chief physician, the First People’s Hospital of Foshan, Foshan 528000, Guangdong Province, China
  • About author:Huang Xingqiu, Associate chief physician, the First People’s Hospital of Foshan, Foshan 528000, Guangdong Province, China

Abstract:

BACKGROUND: Microglia, an innate immunocyte of central nervous system, has been shown to be involved in the regulation of neuroinflammation following central nervous system injury. Methylprednisolone pulse therapy is a common clinical treatment for early spinal cord injury, but its effect on the neuroinflammation after spinal cord injury is unclear.
OBJECTIVE: To observe the effect of methylprednisolone on inflammation mediated by activated microglia after spinal cord injury.
METHODS: Thirty-six Sprague-Dawley rats (provided by Shanghai Slack Laboratory Animals Co., Ltd.) were randomly divided into sham (laminectomy plus 0.9% sodium chloride ), modeling (spinal cord injury model plus 0.9% sodium chloride) and methylprednisolone groups (spinal cord injury model plus injection of methylprednisolone via tail vein) (n=12/group). The spinal cord injury model was established with NYU spinal cord impactor. Three days after administration, the morphology of Nissl body in neurons was observed under light microscope. The levels of interleukin-1β and interleukin-18 in venous blood were detected by ELISA. The number of IBA-1/ED-1 positive activated microglia was tested by laser confocal scanning microscope. The expression of ED-1 protein was detected by western blot assay. The expression levels of interleukin-1β and interleukin-18 mRNA were detected by qPCR.
RESULTS AND CONCLUSION: (1) Nissl staining results revealed that methylprednisolone can improve the morphology of neuron after spinal cord injury, and promote neuron repair. (2) Compared with the modeling group, the levels of interleukin-1β and interleukin-18 in the methylprednisolone group were significantly decreased (P < 0.05). (3) The number of IBA-1/ED-1 positive activated microglia in the methylprednisolone group was significantly less than that in the modeling group (P < 0.05). (4) The expression level of ED-1 protein in the methylprednisolone group was significantly lower than that in the modeling group (P < 0.05). (5) The expression levels of interleukin-1β and interleukin-18 mRNA in the methylprednisolone group were significantly lower than those in the modeling group. (6) To conclude, the mechanism of methylprednisolone inhibiting inflammation is related to inhibiting inflammation induced by activated microglial after spinal cord injury, which is conducive to the recovery of neurons.

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松组织工程

Key words: spinal cord injury, methylprednisolone, microglia, inflammation, ED-1 protein, interleukin-18 mRNA, injection via tail vein

CLC Number: